News and Events

Keep up-to-date on recent events, webinars and releases from ArcherDX.



Aug
2
2017

ArcherDX expands blood-based mutation assay portfolio with new myeloid panels

ArcherDX launches two new NGS-based NGS-based variant-detection assays, the 37-gene VariantPlex Core Myeloid and 72-gene VariantPlex Myeloid panel with unprecedented levels of confident mutation detection.


Jun
12
2017

ArcherDX presents at EHA 2017 in Madrid, Spain

ArcherDX presents at the 22nd European Hematology Association Congress in Madrid, Spain


Apr
24
2017

Archer sponsors Breast Cancer research platform

ArcherDX is partnering with Susan G. Komen Colorado and the University of Colorado Cancer Center to create a local event to connect community physicians, patients, and advocates with academic researchers and industry leaders. Our vision is to provide an educational forum to raise awareness about advances in breast cancer research, treatment, and testing.


Apr
20
2017

Archer at Immunology 2017

Archer exhibits at the American Association of Immunologists Annual Meeting–Immunology 2017 in Washington, DC. At the largest annual gathering of immunologists worldwide, scientists discuss breakthroughs across the full spectrum of topics in the Immunology.


Apr
19
2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017

Archer attends the Children's Oncology Group Cytogenetics Workshop 2017


Apr
19
2017

Archer presents workshop at Biomarkers and Immuno-Oncology World Congress 2017

We'll be exhibiting at Cambridge Healthtech Institute’s Thirteenth Annual Biomarkers and Immuno-Oncology World Congress and will presenting a poster and a workshop featuring on B- and T-Cell Immune Repertoire Characterization by Anchored Multiplex PCR and Next-Generation Sequencing. This conference is dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines.


Apr
18
2017

Archer at 106th Annual Meeting of Japanese Society of Pathology in Tokyo

We'll be co-attending with Illumina at the inaugural Japanese Society of Pathology in Tokyo. We'll be presenting five posters at this event and giving away corresponding poster flyers with the lead scientist contact info for later review. This gathering will strive to establish a focus on diagnosis that is based on an integrated understanding of disease through the use of high-sensitivity, high-volume analytical technologies like next-generation sequencers and embrace the ideal of giving something back to medicine and society as the goal of pathology.


Apr
3
2017

Meet us at the Rocky Mountain Blood Cancer Conference

Archer is Denver on April 8th promoting awareness of NGS in blood cancer cancer research at the Rocky Mountain Blood Cancer Conference hosted by the Leukemia and Lymphoma Society. This a free educational conference for patients, survivors, caregivers and healthcare professionals.


Apr
3
2017

ArcherDX announces strategic partnership with Chinese firm HeliTec for NGS-based diagnostic development

ArcherDX, the leader in NGS-based oncology sequencing applications, and the precision medicine company HeliTec announced today a strategic partnership to advance NGS-based cancer diagnostic development in China. The partnership will entail co-developing and cross-licensing NGS-based technologies with the goal of registering oncology diagnostic kits with the Chinese Food and Drug Administration (CFDA).

Subscribe to stay in the loop







How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2017 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.